FDA has recently issued a warning against the antibiotic, Azithromycin, which is commonly used to treat various infections of eye, ear and throat. Azithromycin, well known as Zithromax or Z- Pak is manufactured by Pfizer and is available as tablets or liquid.
FDA in its statement notes that Zithromax may disturb the electrical activity of heart and cause irregular heartbeats.
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they lead to higher standards of patient care.
Advertisement
FDA warns doctors against prescribing the drug to patients with heart problems and magnesium or potassium deficiencies. The drug may also cause side effects, such as abdominal pain, diarrhea, nausea and vomiting.
Pfizer has updated the drug's label about the abnormality in some patients and has noted that majority of the patients are not affected by the drug.
Source: Medindia
Source: Medindia
Drug Resistance - Antibiotic Resistance
Drug resistance is often a problem in malaria, tuberculosis, HIV, sexually transmitted diseases and hospital acquired diseases. Judicious use of antibiotics can control the problem.
Advertisement
 Antibiotic Resistance is a Major Global ThreatBritain's chief medical officer has said that resistance to antibiotics is a 'catastrophic' global threat. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
